Authors:
STIGBRAND T
ANDRES C
BELLANGER L
OMARY MB
BODENMULLER H
BONFRER H
BRUNDELL J
EINARSSON R
ERLANDSSON A
JOHANSSON A
LECA JF
LEVI M
MEIER T
NAP M
NUSTAD K
SEGUIN P
SJODIN A
SUNDSTROM B
VANDALEN A
WIEBELHAUS E
WIKLUND B
ARLESTIG L
HILGERS J
Citation: T. Stigbrand et al., EPITOPE SPECIFICITY OF 30 MONOCLONAL-ANTIBODIES AGAINST CYTOKERATIN ANTIGENS - THE ISOBM TD5-1 WORKSHOP, Tumor biology, 19(2), 1998, pp. 132-152
Authors:
NYBERG L
WINQUIST L
ULLEN A
BRUNDELL J
HAGLID KG
STIGBRAND T
Citation: L. Nyberg et al., LIAISON(R) SANGTEC(R)-100 A NEW CHEMILUMINESCENCE IMMUNOASSAY FOR THEDETERMINATION OF PROTEIN S-100B IN SERUM, Clinical chemistry, 43, 1997, pp. 210-210
Authors:
NYBERG L
KROON R
ULLEN A
BRUNDELL J
HAGLID KG
STIGBRAND T
Citation: L. Nyberg et al., SANGTEC(R)100 LIA A SENSITIVE MONOCLONAL ASSAY FOR MEASURING PROTEIN S-100B IN SERUM SAMPLES, Clinical chemistry, 43, 1997, pp. 590-590
Authors:
BEZZEGH A
SCHUMANN B
OHRVIK A
BRUNDELL J
HIRSCHBERG L
Citation: A. Bezzegh et al., COMPARATIVE-ANALYSIS OF 2 CYTOKERATIN IMMUNOASSAYS (CYFRA-21-1 AND TPA-M) ON BLOOD-DONOR AND LUNG-CANCER SERUM SAMPLES, Clinical chemistry, 43, 1997, pp. 594-594
Authors:
FERNO M
BENDAHL PO
BORG A
BRUNDELL J
HIRSCHBERG L
OLSSON H
KILLANDER D
Citation: M. Ferno et al., UROKINASE PLASMINOGEN-ACTIVATOR, A STRONG INDEPENDENT PROGNOSTIC FACTOR IN BREAST-CANCER, ANALYZED IN STEROID-RECEPTOR CYTOSOLS WITH A LUMINOMETRIC IMMUNOASSAY, European journal of cancer, 32A(5), 1996, pp. 793-801
Authors:
BORG A
LENNERSTRAND J
STENMARKASKMALM M
FERNO M
BRISFORS A
OHRVIK A
STAL O
KILLANDER D
LANE D
BRUNDELL J
Citation: A. Borg et al., PROGNOSTIC-SIGNIFICANCE OF P53 OVEREXPRESSION IN PRIMARY BREAST-CANCER - A NOVEL LUMINOMETRIC IMMUNOASSAY APPLICABLE ON STEROID-RECEPTOR CYTOSOLS, British Journal of Cancer, 71(5), 1995, pp. 1013-1017